Thorax perfusion CT in non-small cell lung cancer

被引：19
|
作者：
Ovali, Gulgun Yilmaz
Sakar, Aysin
Goektan, Cihan
Celik, Pinar
Yorgancioglu, Arzu
Nese, Nalan
Pabuscu, Yueksel
机构：
[1] Celal Bayar Univ, Dept Radiol, Manisa, Turkey
[2] Celal Bayar Univ, Dept Pulmonol, Manisa, Turkey
[3] Celal Bayar Univ, Dept Pathol, Manisa, Turkey
来源：
COMPUTERIZED MEDICAL IMAGING AND GRAPHICS | 2007年 / 31卷 / 08期
关键词：
perfusion; non-small cell lung tumor; computed tomography; thorax;
D O I：
10.1016/j.compmedimag.2007.08.005
中图分类号：
R318 [生物医学工程];
学科分类号：
0831 ;
摘要：
Objectives: We aimed to determine the perfusion differences according to the histological type, stage, volume and prognoses in the non-small cell carcinoma by thorax perfusion CT. Materials and methods: Twenty-four non-small cell carcinoma patients were included in the study. Thorax perfusion CT was done to evaluate the tumors in terms of perfusion parameters: blood flow (BF) and time to peak (TTP) values. Results: The total blood flow of the tumor in squarnous cell carcinoma was significantly higher than adenocarcinoma (P = 0.03 1). There was no statistical difference between the perfusion parameters and other parameters. Conclusions: Perfusion CT may help us in evaluating non-small cell carcinomas. (c) 2007 Elsevier Ltd. All rights reserved.
引用
收藏
页码：686 / 691
页数：6
相关论文
共 50 条
  • [41] Immunotherapy for non-small cell lung cancer
    Vafadar, Sam
    [J]. JAAPA-JOURNAL OF THE AMERICAN ACADEMY OF PHYSICIAN ASSISTANTS, 2019, 32 (09): : 37 - 42
  • [42] METASTASE IN NON-SMALL CELL LUNG CANCER
    Luan Van Pham
    Tien Dinh Nguyen
    Hai Minh Nguyen
    Tien Dao Nguyen
    Duyen Thi Thi
    Son Van Nguyen
    Dai Van Tran
    [J]. RESPIROLOGY, 2019, 24 : 272 - 272
  • [43] Immunotherapy in non-small cell lung cancer
    Peters, Geoffrey
    John, Thomas
    [J]. CANCER FORUM, 2018, 42 (01) : 24 - 28
  • [44] Paclitaxel for non-small cell lung cancer
    Ramalingam, S
    Belani, CP
    [J]. EXPERT OPINION ON PHARMACOTHERAPY, 2004, 5 (08) : 1771 - 1780
  • [45] Pneumonectomy for non-small cell lung cancer
    Ichiki, Yoshinobu
    Nagashima, Akira
    Chikaishi, Yasuhiro
    Yasuda, Manabu
    [J]. SURGERY TODAY, 2012, 42 (09) : 830 - 834
  • [46] Docetaxel and non-small cell lung cancer
    Le Guen, Y
    Le Cesne, A
    [J]. BULLETIN DU CANCER, 2004, 91 (03) : 263 - 270
  • [47] Sorafenib in non-small cell lung cancer
    Zhang, Jianjun
    Gold, Kathryn A.
    Kim, Edward
    [J]. EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2012, 21 (09) : 1417 - 1426
  • [48] Non-small cell lung cancer in the elderly
    Makrantonakis, PD
    Galani, E
    Harper, PG
    [J]. ONCOLOGIST, 2004, 9 (05): : 556 - 560
  • [49] Bevacizumab in non-small cell lung cancer
    Di Costanzo, Francesco
    Mazzoni, Francesca
    Mela, Marinella Micol
    Antonuzzo, Lorenzo
    Checcacci, Daniele
    Saggese, Matilde
    Di Costanzo, Federica
    [J]. DRUGS, 2008, 68 (06) : 737 - 746
  • [50] Radiotherapy of non-small cell lung cancer
    Jassem, J
    [J]. 8TH CENTRAL EUROPEAN LUNG CANCER CONFERENCE, 2002, : 207 - 214
12345